Development of a GBM vaccine based on HLA-A2-associated peptides

C.H. Herold-Mende, V. Dutoit, P. Beckhove, P.Y. Dietrich, H.S. Singh-Jasuja & A. Unterberg
Objective: Cancer vaccines are an attractive alternative to standard cancer treatments and are already being tested in humans. Ideally, T-cell-mediated tumor immunotherapy is directed against several tumor-associated antigens in order to circumvent the so called 'immune escape'. Methods:[for full text, please go to the a.m. URL]